P50 gating
Showing 1 - 25 of >10,000
Schizophrenia Trial in Denver (Ondansetron followed by , Placebo followed by Ondansetron)
Completed
- Schizophrenia
- Ondansetron followed by placebo
- Placebo followed by Ondansetron
-
Denver, ColoradoDenver VAMC
Jul 20, 2021
EX-PRESS® P-50 and EX-PRESS® P-200
Not yet recruiting
- Glaucoma
- EX-PRESS P-50 filtration device
- EX-PRESS P-200 filtration device
- (no location specified)
Oct 31, 2023
Bioequivalence, Diabetes, Type 2 Trial in Mount Royal (Sitagliptin/Metformin HCl 50/850 mg film-coated tablet)
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/850 mg film-coated tablet
-
Mount Royal, Quebec, CanadaAlgorithme Pharma
Sep 20, 2022
Bioequivalence, Type 2 Diabetes Trial in Mount Royal (Sitagliptin/metformin HCl (HCl) 50/1000 mg film-coated tablet)
Completed
- Bioequivalence
- Type 2 Diabetes
- Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet
-
Mount Royal, Quebec, CanadaAlgorithme Pharma
Sep 20, 2022
Schizophrenia Trial in Glendale, Rouffach, Toul (NSA-789 at 2 different doses)
Withdrawn
- Schizophrenia
- NSA-789 at 2 different doses
-
Glendale, California
- +2 more
Aug 17, 2021
Breast Cancer Trial in New York (Multicomponent Adherence Intervention)
Recruiting
- Breast Cancer
- Multicomponent Adherence Intervention
-
New York, New YorkColumbia University Medical Center
Nov 6, 2023
SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)
Recruiting
- SARS-CoV-2 Infection
- B/HPIV3/S-6P
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Aug 30, 2023
Bioequivalence Trial in Mount Royal (Lamotrigine ER tablet 50mg)
Completed
- Bioequivalence
- Lamotrigine ER tablet 50mg
-
Mount Royal, Quebec, CanadaAlgorithme Pharma
Dec 6, 2021
Healthy Trial in Québec (Camlipixant + Gemfibrozil, Dabigatran etexilate + camlipixant)
Not yet recruiting
- Healthy
- Camlipixant + Gemfibrozil
- Dabigatran etexilate + camlipixant
-
Québec, Quebec, CanadaSyneos Health
Jul 17, 2023
Healthy Trial in Québec (Camlipixant + Rifampin, Camlipixant + Rabeprazole)
Not yet recruiting
- Healthy
- Camlipixant + Rifampin
- Camlipixant + Rabeprazole
-
Québec, Quebec, CanadaSyneos Health
Jun 2, 2023
Nasonex® Nasal Suspension 50 µg Long-term Designated Drug Use
Completed
- Allergic Rhinitis
- mometasone furoate
- (no location specified)
Feb 7, 2022
Healthy Trial in Mexico City (Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg, Pregabalin 150mg, Tramadol 50 mg)
Completed
- Healthy
- Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg
- +2 more
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
May 19, 2022
Cervix Cancer, HPV Testing, Postmenopausal Women Trial in Randers (cytology, p16/ki67 dual stain cytology (DS), extended
Recruiting
- Cervix Cancer
- +2 more
- cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load,
-
Randers, Central Denmark Region, DenmarkDepartment of Pathology
Feb 3, 2023
Migraine Headache Trial (rizatriptan benzoate (MK0462), Comparator: sumatriptan, Comparator: Placebo)
Completed
- Migraine Headache
- rizatriptan benzoate (MK0462)
- +2 more
- (no location specified)
Feb 1, 2022
Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul (PPI, P-CAB 25, P-CAB 50)
Recruiting
- Coronary Artery Disease
- +3 more
- PPI
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Mar 6, 2022
Group A Streptococcal Infection Trial in Edmonton (p*17-K4S2 (25 µg/mL), J8-K4S2 (100 µg/mL), p*17-K4S2 (50 µg/mL))
Not yet recruiting
- Group A Streptococcal Infection
- p*17-K4S2 (25 µg/mL)
- +4 more
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital
Jul 26, 2022
Based Care for Youth in Low-resource Environments
Recruiting
- Improving Therapist Use of Measurement-based Care
-
Seattle, WashingtonKPWHRI
Nov 30, 2022
Sickle Cell Disease Trial in Paris (Famotidine 400 mg/50 mL)
Recruiting
- Sickle Cell Disease
- Famotidine 400 mg/50 mL
-
Paris, FranceNecker - Enfants malades Hospital; Department of Pediatrics and
Oct 10, 2022
Different Gating Techniques for PET Image of Lung and Liver
Recruiting
- Lung; Nodule
- Liver Metastases
-
Monaco, MonacoCentre Hospitalier Princesse Grace
Mar 9, 2023
Covid19 Trial in Ottawa (drug, dietary supplement, other)
Suspended
- Covid19
- Vitamin D3 50,000 IU
- +4 more
-
Ottawa, Ontario, CanadaThe Centre for Health Innovation
Aug 8, 2022
Drug Interaction Trial in Montréal (ATI-2173 50 mg, Tenofovir 300Mg Oral Tablet)
Completed
- Drug Interaction
- ATI-2173 50 mg
- Tenofovir 300Mg Oral Tablet
-
Montréal, Quebec, CanadaAltasciences
Feb 3, 2022
Healthy Adults Trial in Dallas (Sitravatinib 50 mg, Sitravatinib 100 mg, Itraconazole)
Recruiting
- Healthy Adults
- Sitravatinib 50 mg
- +3 more
-
Dallas, TexasLabcorp Drug Development Clinical Research Unit
Feb 23, 2022
Asthma Trial (mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID,
Completed
- Asthma
- mometasone furoate combination MDI 200/10 mcg BID
- +3 more
- (no location specified)
Feb 7, 2022
COPD (COPD) Trial in Bordeaux (Seretide® Diskus® 500/550 µg, Ultibro® Breezhaler® 110/50 µg, Spiriva® Respimat® 2,5 µg)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- Seretide® Diskus® 500/550 μg
- +2 more
-
Bordeaux, FranceCIC-P - Centre François Magendie - G3 - Hôpital Haut-Lévêque
Feb 8, 2022
Sunburn, Sun Damaged Skin, Overexposure to Sun Rays Trial in Chile, Peru, United States (otc sunscreens, sun protection fabrics,
Enrolling by invitation
- Sunburn
- +2 more
- otc sunscreens
- +2 more
-
San Diego, California
- +4 more
Oct 24, 2022